Recruiting Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy NCT07555210 Conditions Adenocarcinoma, Breast Cancer (Triple Negative Breast Cancer (TNBC)), Breast Diseases, +44 more Locations Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States View Trial Details
